Language selection

Search

2012-02-13 - Not specified - 22 Years old

409901

Adverse reaction report number 409901
Latest AER version number 0
Market authorization holder AER number ALL1201301021
Initial received date 2012-02-13
Latest received date 2012-02-13
Age 22 Years
Gender Not specified
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report Community
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 10MGCAPSULE, EXTENDED RELEASESuspectOral10 Milligram1 every 1 Day(s)31 Day(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Electrocardiogram QT prolonged
Date modified: